Between 2004 and 2014, the number of overall new HCV cases increased 133%. There was a 325% increase for persons aged 30-39. There was a 400% increase for person aged 18-29. The drug overdose rate increased between 2000 and 2019, with 71,999 deaths in 2019. Source: CDC

Since its founding in 1992, NASTAD members have been concerned about the role of drug use in the transmission of HIV and HCV, health outcomes for persons living with HIV and hepatitis who use drugs, and the structural and policy barriers to effectively address the prevention, care, and treatment needs of persons who inject drugs. To address the prevention, care, treatment, and policy needs related to drug user health, NASTAD has partnered with federal, state, and local governments and community partners to continue to advocate for a comprehensive response to these environmental crises to address this important population. In addition to partnerships with key organizations, NASTAD produces resources, provides technical assistance to our members and community-based harm reduction programs, and advocates for an effective science-based public health approach to address the needs of people who inject drugs.

Request Technical Assistance

If you would like to request TA from NASTAD, please reach out to the Drug User Health team directly at

As of Friday, December 1, 2023, NASTAD, National Harm Reduction Coalition, and University of Washington are no longer affiliated with the CDC- and SAMHSA-funded National Harm Reduction TA Center. We hope to have more information soon on the status of the TA Center and what this transition means for you as community members requesting trusted harm reduction TA and resources. In the meantime, we at NASTAD remain committed to providing assistance to SSPs and community-based harm reduction programs, people who use drugs, and health departments supporting these efforts across the country. Please feel free to reach out to our team at to discuss potential options for continued TA.